InnovFest 2012 is an exciting festival of innovation-related activities. Organised by NUS Enterprise for the third year running, this event aims to boost technology transfer, entrepreneurship and investment amongst Asia’s business, academic and technology communities.  Plenary sessions, workshops and networking events will update participants on the latest trends in intellectual property management and commercialisation, as well as provide direct access to leading startups, business professionals, and investors.

Some 300-500 participants are expected to attend InnovFest 2012. These include technology transfer professionals, innovators, researchers, industry, entrepreneurs, the financial community, and government agencies. InnovFest 2012 is the must-attend event for anyone keen to know how to bring their technologies to the market, discover new innovations and meet with leaders within the technology commercialisation and entrepreneurship sectors.

18 April 2012 - Pre-conference workshops on Valuation by Ashley Stevens

Conducted by former AUTM President, Dr Ashley Stevens, CLP, RTTP, this all-day course is designed to provide technology transfer progessionals with the basics of technology valuation as applied to both industry and academic technology licensing.

Pre-conference workshops on topics such as valuation, negotiation, technology transfer for small businesses, and patent mapping. All workshops are designed and conducted by AUTM, LES and PatSnap.

19 - 20 April 2012 - Technology Commercialisation Forum /AUTM Asia 2012

Technology Commercialisation Forum (TCF) to be held concurrently with the Association of University Technology Managers (AUTM) Asia conference.

Topics of interest include : 

• “New Opportunities in Graphene” by Professor Antonio H. Castro Neto, Director, Graphene Research Centre and Distinguished Professor, Department of Physics, National University of Singapore, and Professor of Physics at Boston University
• “New Business Models for Effective Technology Transfer to Industry”, with represented speakers from Asia, US and Europe
• “Public Policy Driving Technology Transfer”, with representations from 5 countries and 3 continents.

19 April 2012 -  Technology Pitching @ 2.30pm onwards

An opportunity to present technology from your organisation to an international audience!

Click here to submit your ideas by 29 February 2012. Shortlisted candidates will be informed by 29 February 2012 and earn the opportunity to present their technology to an international audience. Candidates not selected for oral presentation may be granted presence at the conference to showcase their technology at the poster pitching arena.

Two technology pitching sessions will be held in the area of:
• Medical Devices and Diagnostics
• Clean Tech Sustainability

*All shortlisted candidates are required to purchase their own conference pass for access to AUTM Asia /Technology Commercialisation Forum 2012.

20 April 2012 - The Enterprise Connection

A networking dinner, which enables entrepreneurs, inventors, and other key stakeholders in NUS Enterprise’s global network to connect and share ideas.  An internationally-recognised entrepreneur will share his/her views on entrepreneurship, through the Global Entrepreneurial Leadership speaker series.  In addition, the Innovation & Enterprise Award will be given out, a prestigious award that recognizes individuals and companies within the NUS community, who have achieved significant accomplishments in innovation and entrepreneurship.

InnovFest will be held from 18-20 April 2012 at the Orchard Hotel

Registration is now open !

Event No. 1

Lunchtime discussion probing some of the regulatory quandaries of the 21st century

Dr Sylvain Mandeville: Director of Bioanalytical Services CPR Pharma Services Pte Ltd.

“Raising the bar of regulatory compliance: Current best practice in bioanalysis”

Dr Mandeville will discuss new trends and future directions such as CFR 21 Part 11 compliance, FDA trends, paperless laboratories, recent White papers that will shape the FDA guidance documents of the future.

Dr Mandeville has worked in the fields of general management, business development, bioanalytical method development and the implementation of quality and laboratory information management systems. Dr Mandeville was Director of Bioanalytical Services at Ricerca Biosciences LLC between 2008 and 2010, Senior Director Bioanalytical Services and Business Development at LAB Research Ltd between 2006 and 2008, a consultant responsible for establishment of a new GLP bioanalytical facility for LAB Research in Hungary between 2004 and 2006, Senior Director at Warnex Analytical/Bioanalytical Services Inc between 2001 and 2004, Head of Bioanalytical Services at Phoenix International Life Sciences between 1999 and 2001, and occupied positions of increasing responsibility at LAB Pharmacological Research International between 1993 and 1999. He holds a PhD in Analytical Chemistry and a BSc in Food Sciences and Agricultural Chemistry from McGill University.

Dr Jean-Marie Houle: Director of Clinical Science Sales and Business Development CPR Pharma Services Pty Ltd.

“Efficient First-In-Human study designs; the standard more than the exception”

Dr Houle will discuss the progression in adaptive clinical trial design, and the associated advantages.

Dr Houle is a pharmacokineticist by training and is an expert in drug development. He has worked in the fields of operations, management, business development, pharmacokinetics, clinical pharmacology and as a consultancy to the pharmaceutical industry. Dr Houle was VP of Clinical Operations at Anapharm between 2007-2010; VP of Research and Development at Chronogen between 2006 and 2007 where he headed up R and D, a consultant to the pharmaceutical industry where he assessed clients PK strategy and evaluated PK/Clinical Pharmacology packages, between 2005 and 2006, Director of PK and Clinical Pharmacology at QLT Inc where his role was key in supporting the regulatory submissions for approval of Visudyne globally between 1998 and 2005 and Director of Scientific Affairs at LAB Pharmacology Research from 1987-1997. He holds a PhD in Pharmaceutical Science and a BSc in Pharmacy from The University of Montreal.

Date: 29 February 2012.
Time: 12pm – 2pm
Location: Aspiration, Matrix at Biopolis
Cost: $30 to Members and $50 for non-members. Individual membership of $50 can be paid at the door or directly online. If you take an individual membership, your money will be returned if your company enrolls as a Corporate Member for $1000 during the same financial year.

Please RSVP before 20 February 2012 to Yvette Flanigan - This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Event No. 2

BioSingapore Networking Event.

Wednesday 29 February 2012 from 18:30 – late.

As always, this networking event will provide a good opportunity for you to mingle and get to know the other members better for potential future linkups and to enhance your professional and personal contact database. It’s a lucky date that won’t come around again until the next leap year.
Contract research organizations’ are set to be the next area of growth in the Biotech industry. This month Mr. Jason Valentine Chief Executive Officer and founder of CPR Australia will give a 20 minute talk on Why Singapore? Jason will briefly discuss why CPR, a contract research company, chose to set up operations in Singapore.
Please join us at:

"B"
One Rochester
8 Rochester Park
Singapore 139219

The event is $30 to Members and $40 for non-members. Individual membership of $50 can be paid at the door or directly online. If you take an individual membership, your money will be returned if your company enrolls as a Corporate Member for $1000 during the same financial year.

Hope to you'll be able to join us; do bring your friends and colleagues.

Please RSVP before 22 February 2012 to Yvette Flanigan - This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Date: 10 October to 12 October 2011

Venue: Amphitheatre, Level 2, Duke-NUS

This symposium focuses on translational medicine, particularly that which involves clinical application of advances in cellular and molecular biology and genetics. The sessions will explore investigational medicine from the vantage point of clinician scientists, and the theme running throughout the entire symposium is that of human investigation.

The objective of this gathering of investigators from throughout Singapore and Duke University is to develop further interactions between these two centers of academic medicine, and catalyze innovative collaborations to advance both the development of translational medicine for all partners and its realization for clinical application and commercialization.

Speakers from Duke University, Duke-NUS, local healthcare and research institutions, as well as the pharmaceutical industry will be sharing their insights.

We welcome all participants to this exciting event, which is designed to provide everyone with an opportunity to engage in discussions. In addition to the formal talks by leading investigators, we would particularly like to point out the workshops on the final day of the program where all attendees are encouraged to participate. 

Registration is free of charge.  

For more information, contact Ms Jacqueline Goh at tel: +65 6601 2275 or email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it .